Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAG | P20916 | 4/20 | 0.41 |
| ▸ | CD22 | P20273 | 7/20 | 0.40 |
| ▸ | NANP | Q8TBE9 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | SIGLEC7 | Q9Y286 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10084278 | 0.85 | L3MBTL1 (0.45) | MAGCD22L3MBTL1 | |
| SCHEMBL16348268 | 0.85 | L3MBTL1 (0.45) | MAGCD22L3MBTL1 | |
| SCHEMBL28320235 | 0.85 | L3MBTL1 (0.45) | MAGCD22L3MBTL1 | |
| SCHEMBL17546165 | 0.85 | L3MBTL1 (0.45) | MAGCD22L3MBTL1 | |
| SCHEMBL31695084 | 0.82 | NANP (0.52) | MAGCD22NANPL3MBTL1SIGLEC7 | |
| SCHEMBL16190386 | 0.81 | NANP (0.50) | MAGCD22NANPL3MBTL1SIGLEC7 | |
| SCHEMBL13190938 | 0.81 | NANP (0.50) | MAGCD22NANPL3MBTL1SIGLEC7 | |
| SCHEMBL18333560 | 0.81 | NANP (0.50) | MAGCD22NANPL3MBTL1SIGLEC7 | |
| SCHEMBL18333558 | 0.81 | NANP (0.50) | MAGCD22NANPL3MBTL1SIGLEC7 | |
| SCHEMBL8502846 | 0.81 | NANP (0.50) | MAGCD22NANPL3MBTL1SIGLEC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170157260-A1 | Glycosylated Polypeptide and Drug Composition Containing said Polypeptide | GLYTECH, INC. (JP) | 2017-06-08 | — | — | US | disclosed |
| US-20160368961-A1 | Glycosylated Polypeptide and Drug Composition Containing said Polypeptide | GLYTECH, INC. (JP) | 2016-12-22 | — | — | US | disclosed |
| US-9422357-B2 | Glycosylated polypeptide and drug composition containing said polypeptide | GLYTECH, INC. (JP) | 2016-08-23 | — | — | US | disclosed |
| US-20140336116-A1 | Glycosylated Polypeptide and Drug Composition Containing Said Polypeptide | GLYTECH, INC. (JP) | 2014-11-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170157260-A1 | Glycosylated Polypeptide and Drug Composition Containing said Polypeptide | GIPR, SSTR4, SSTR3 | MAG 784/4885CD22 265/4885NANP 953/4885 |
| US-20140336116-A1 | Glycosylated Polypeptide and Drug Composition Containing Said Polypeptide | GIPR, SSTR4, SSTR5 | MAG 778/4885CD22 275/4885NANP 978/4885 |
| US-20160368961-A1 | Glycosylated Polypeptide and Drug Composition Containing said Polypeptide | GIPR, SSTR3, SSTR4 | MAG 766/4885CD22 276/4885NANP 878/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.